1
|
Yang P, Wang S, Zhong C, Yin J, Yang J, Wang A, Xu T, Zhang Y. Association of Cardiac Biomarkers in Combination With Cognitive Impairment After Acute Ischemic Stroke. J Am Heart Assoc 2024; 13:e031010. [PMID: 38390800 PMCID: PMC10944059 DOI: 10.1161/jaha.123.031010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/16/2023] [Accepted: 01/24/2024] [Indexed: 02/24/2024]
Abstract
BACKGROUND Poststroke cognitive impairment is a severe and common clinical complication that constitutes a substantial global health burden. We aimed to evaluate the association of 3 cardiac biomarkers in combination with poststroke cognitive impairment and their prognostic significance. METHODS AND RESULTS This prospective study included 566 patients with ischemic stroke. Cardiac biomarkers, including sST2 (soluble suppression of tumorigenicity-2 receptor), GDF-15 (growth differentiation factor-15), and NT-proBNP (N-terminal pro-B-type natriuretic peptide), were measured. Cognitive impairment was defined as a Mini-Mental State Examination score of <27 or a Montreal Cognitive Assessment score of <25 at 3 months after ischemic stroke. Odds of cognitive impairment 3 months after ischemic stroke increased with the number of elevated cardiac biomarkers (sST2, GDF-15, and NT-proBNP; Ptrend<0.001). The multivariable adjusted odds ratios (95% CIs) of cognitive impairment defined by the Mini-Mental State Examination and Montreal Cognitive Assessment were 2.45 (1.48-4.07) and 1.86 (1.10-3.14) for the participants with ≥2 elevated cardiac biomarkers, respectively, compared with those without any elevated cardiac biomarker. Additionally, higher cardiac biomarker scores were associated with an increased risk of cognitive impairment (Ptrend<0.05). Simultaneously adding all 3 cardiac biomarkers to the basic model with traditional risk factors significantly improved the risk prediction of Mini-Mental State Examination-defined cognitive impairment (net reclassification improvement=34.99%, P<0.001; integrated discrimination index=2.67%, P<0.001). Similar findings were observed using the Montreal Cognitive Assessment scores. CONCLUSIONS An increased number of elevated novel cardiac biomarkers were associated with an increased odds of poststroke cognitive impairment, suggesting that a combination of these cardiac biomarkers may improve the risk prediction of cognitive impairment. REGISTRATION URL: https://www.clinicaltrials.gov; Unique identifier: NCT01840072.
Collapse
Affiliation(s)
- Pinni Yang
- Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric DiseasesSuzhou Medical College of Soochow UniversitySuzhouChina
| | - Shuyao Wang
- Department of NeurologyTongliao Municipal HospitalTongliaoChina
| | - Chongke Zhong
- Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric DiseasesSuzhou Medical College of Soochow UniversitySuzhouChina
| | - Jieyun Yin
- Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric DiseasesSuzhou Medical College of Soochow UniversitySuzhouChina
| | - Jingyuan Yang
- Department of Epidemiology, School of Public HealthGuizhou Medical UniversityGuiyangChina
| | - Aili Wang
- Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric DiseasesSuzhou Medical College of Soochow UniversitySuzhouChina
| | - Tan Xu
- Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric DiseasesSuzhou Medical College of Soochow UniversitySuzhouChina
| | - Yonghong Zhang
- Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric DiseasesSuzhou Medical College of Soochow UniversitySuzhouChina
| |
Collapse
|
2
|
Bevers MB. Refining the continuum of neurologic prognosis - Predicting brain death after cardiac arrest. Resuscitation 2023; 192:109990. [PMID: 37805059 DOI: 10.1016/j.resuscitation.2023.109990] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2023] [Accepted: 09/27/2023] [Indexed: 10/09/2023]
Affiliation(s)
- Matthew B Bevers
- Division of Neurocritical Care, Brigham and Women's Hospital, Boston, MA, United States
| |
Collapse
|
3
|
Resuscitation highlights in 2021. Resuscitation 2022; 172:64-73. [PMID: 35077856 DOI: 10.1016/j.resuscitation.2022.01.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2022] [Indexed: 11/21/2022]
Abstract
BACKGROUND This review is the latest in a series of regular annual reviews undertaken by the editors and aims to highlight some of the key papers published in Resuscitation during 2021. METHODS Hand-searching by the editors of all papers published in Resuscitation during 2021. Papers were selected based on then general interest and novelty and were categorised into themes. RESULTS 98 papers were selected for brief mention. CONCLUSIONS Resuscitation science continues to evolve and incorporates all links in the chain of survival.
Collapse
|
4
|
Müller J, Bissmann B, Becker C, Beck K, Loretz N, Gross S, Amacher SA, Bohren C, Pargger H, Tisljar K, Sutter R, Marsch S, Hunziker S. Neuron-Specific Enolase (NSE) Predicts Long-Term Mortality in Adult Patients after Cardiac Arrest: Results from a Prospective Trial. MEDICINES 2021; 8:medicines8110072. [PMID: 34822369 PMCID: PMC8624292 DOI: 10.3390/medicines8110072] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/16/2021] [Revised: 11/09/2021] [Accepted: 11/12/2021] [Indexed: 11/22/2022]
Abstract
Background: We investigated whether Neuron-specific enolase (NSE) serum concentration predicts long-term mortality and poor neurological outcome in adult cardiac arrest patients. Methods: Within this prospective observational study, we included consecutive adult patients admitted to the intensive care unit (ICU) after cardiac arrest. NSE was measured upon ICU admission and on days 1, 2, 3, 5 and 7. Results: Of 403 patients, 176 (43.7%) survived. Median follow-up duration was 43.7 months (IQR 14.3 to 63.0 months). NSE levels on day 3 were increased more than threefold in non-survivors compared to survivors (median NSE (ng/mL) 19.8 (IQR 15.7 to 27.8) vs. 72.6 (IQR 26 to 194)) and showed the highest prognostic performance for mortality compared to other days of measurement, with an AUC of 0.81 and an adjusted hazard ratio of 1.55 (95% CI 1.41 to 1.71, p < 0.001). Subgroup analysis showed an excellent sensitivity and negative predictive value of 100% of NSE in patients <54 years of age. Conclusion: NSE measured three days after cardiac arrest is associated with long-term mortality and neurological outcome and may provide prognostic information that improves clinical decision making. Particularly in the subgroup of younger patients (<54 years), NSE showed excellent negative predictive value.
Collapse
Affiliation(s)
- Jonas Müller
- Department of Medical Communication and Psychosomatic Medicine, University Hospital Basel, 4031 Basel, Switzerland; (J.M.); (B.B.); (C.B.); (K.B.); (N.L.); (S.G.); (S.A.A.); (C.B.)
| | - Benjamin Bissmann
- Department of Medical Communication and Psychosomatic Medicine, University Hospital Basel, 4031 Basel, Switzerland; (J.M.); (B.B.); (C.B.); (K.B.); (N.L.); (S.G.); (S.A.A.); (C.B.)
| | - Christoph Becker
- Department of Medical Communication and Psychosomatic Medicine, University Hospital Basel, 4031 Basel, Switzerland; (J.M.); (B.B.); (C.B.); (K.B.); (N.L.); (S.G.); (S.A.A.); (C.B.)
- Emergency Department, University Hospital Basel, 4031 Basel, Switzerland
- Medical Faculty, University of Basel, 4031 Basel, Switzerland; (H.P.); (K.T.); (R.S.); (S.M.)
| | - Katharina Beck
- Department of Medical Communication and Psychosomatic Medicine, University Hospital Basel, 4031 Basel, Switzerland; (J.M.); (B.B.); (C.B.); (K.B.); (N.L.); (S.G.); (S.A.A.); (C.B.)
| | - Nina Loretz
- Department of Medical Communication and Psychosomatic Medicine, University Hospital Basel, 4031 Basel, Switzerland; (J.M.); (B.B.); (C.B.); (K.B.); (N.L.); (S.G.); (S.A.A.); (C.B.)
| | - Sebastian Gross
- Department of Medical Communication and Psychosomatic Medicine, University Hospital Basel, 4031 Basel, Switzerland; (J.M.); (B.B.); (C.B.); (K.B.); (N.L.); (S.G.); (S.A.A.); (C.B.)
| | - Simon A. Amacher
- Department of Medical Communication and Psychosomatic Medicine, University Hospital Basel, 4031 Basel, Switzerland; (J.M.); (B.B.); (C.B.); (K.B.); (N.L.); (S.G.); (S.A.A.); (C.B.)
- Intensive Care Unit, University Hospital Basel, 4031 Basel, Switzerland
| | - Chantal Bohren
- Department of Medical Communication and Psychosomatic Medicine, University Hospital Basel, 4031 Basel, Switzerland; (J.M.); (B.B.); (C.B.); (K.B.); (N.L.); (S.G.); (S.A.A.); (C.B.)
| | - Hans Pargger
- Medical Faculty, University of Basel, 4031 Basel, Switzerland; (H.P.); (K.T.); (R.S.); (S.M.)
- Intensive Care Unit, University Hospital Basel, 4031 Basel, Switzerland
| | - Kai Tisljar
- Medical Faculty, University of Basel, 4031 Basel, Switzerland; (H.P.); (K.T.); (R.S.); (S.M.)
- Intensive Care Unit, University Hospital Basel, 4031 Basel, Switzerland
| | - Raoul Sutter
- Medical Faculty, University of Basel, 4031 Basel, Switzerland; (H.P.); (K.T.); (R.S.); (S.M.)
- Intensive Care Unit, University Hospital Basel, 4031 Basel, Switzerland
| | - Stephan Marsch
- Medical Faculty, University of Basel, 4031 Basel, Switzerland; (H.P.); (K.T.); (R.S.); (S.M.)
- Intensive Care Unit, University Hospital Basel, 4031 Basel, Switzerland
| | - Sabina Hunziker
- Department of Medical Communication and Psychosomatic Medicine, University Hospital Basel, 4031 Basel, Switzerland; (J.M.); (B.B.); (C.B.); (K.B.); (N.L.); (S.G.); (S.A.A.); (C.B.)
- Medical Faculty, University of Basel, 4031 Basel, Switzerland; (H.P.); (K.T.); (R.S.); (S.M.)
- Correspondence: ; Tel.: +41-61-265-25-25
| |
Collapse
|
5
|
Zook N, Voss S, Blennow Nordström E, Brett SJ, Jenkinson E, Shaw P, White P, Benger J. Neurocognitive function following out-of-hospital cardiac arrest: A systematic review. Resuscitation 2021; 170:238-246. [PMID: 34648921 DOI: 10.1016/j.resuscitation.2021.10.005] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2021] [Revised: 09/28/2021] [Accepted: 10/02/2021] [Indexed: 10/20/2022]
Abstract
OBJECTIVES The primary aim of this review was to investigate neurocognitive outcomes following out-of-hospital cardiac arrest (OHCA). Specifically, the focus was on identifying the different neurocognitive domains that are assessed, the measures used, and the level of, and criteria for, impairment. DESIGN AND REVIEW METHODS A systematic review of the literature from 2006 to 2021 was completed using Medline, Cinahl and Psychinfo. Criteria for inclusion were studies with participants over the age of 18, OHCA and at least one neurocognitive function measure. Qualitative and case studies were excluded. Reviewers assessed criteria and risk of bias using a modified version of Downs and Black. RESULTS Forty-three studies were identified. Most studies had a low risk of bias (n = 31) or moderate risk of bias (n = 11) and one had a high risk; however, only six reported effect sizes or power analyses. Multiple measures of neurocognitive outcomes were used (>50) and level of impairment criteria varied considerably. Memory impairments were frequently found and were also more likely to be impaired followed by executive function and processing speed. DISCUSSION This review highlights the heterogeneity of measures and approaches used to assess neurocognitive outcomes following OHCA as well as the need to improve risk of bias concerning generalizability. Improved understanding of the approaches used for assessment and the subsequent findings will facilitate a standardized evaluation of neurocognitive outcomes following OHCA.
Collapse
Affiliation(s)
- Nancy Zook
- Health and Applied Sciences, University of the West of England, Bristol, UK.
| | - Sarah Voss
- Health and Applied Sciences, University of the West of England, Bristol, UK
| | - Erik Blennow Nordström
- Lund University, Skane University Hospital, Department of Clinical Sciences Lund, Neurology, Lund, Sweden
| | - Stephen J Brett
- Department of Surgery and Cancer, Imperial College London, London, UK
| | | | - Pauline Shaw
- Health and Applied Sciences, University of the West of England, Bristol, UK
| | - Paul White
- Health and Applied Sciences, University of the West of England, Bristol, UK
| | - Jonathan Benger
- Health and Applied Sciences, University of the West of England, Bristol, UK
| |
Collapse
|
6
|
Drabek T. The brain through the looking-glass, and the death that we found there. Resuscitation 2021; 168:225-227. [PMID: 34560236 DOI: 10.1016/j.resuscitation.2021.09.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2021] [Accepted: 09/12/2021] [Indexed: 11/20/2022]
Affiliation(s)
- Tomas Drabek
- Safar Center for Resuscitation Research, Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh, UPMC Presbyterian Hospital, 200 Lothrop St. Suite C-200, Pittsburgh, PA 15213, USA.
| |
Collapse
|